http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MA-51020-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
filingDate 2018-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd63d0fd7fe02cc1c26ff9d9686f036b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_415ff0dfe7def81aa80f89bba01ffb9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff9d614067e2b34a0a0ac0ebf55a78a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_523f4a07260a50d472dc1c0670d75cf9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31ce8d004ff5d96882f686cbc2432a81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfee82999d07236647b2bfbf5163bfa8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f1e697155fc752ab353e3ceb4c96a0e
publicationDate 2021-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MA-51020-A
titleOfInvention IMIDAZOPYRIDIN COMPOUNDS AND THEIR USE AS A MEDICINAL PRODUCT
priorityDate 2017-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67504
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408734456

Total number of triples: 26.